Spontaneous Pneumothorax in Adolescents

Pneumothorax, Spontaneous Clinical Trial

— PNSA  

Official title:

Spontaneous Pneumothorax in Adolescents: Inventory and Management

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06175416
• Other study ID #: 8700
• Status: Recruiting
• Start date: September 1, 2022
• Est. completion date: December 2023

Study information

• Verified date: December 2023
• Source: University Hospital, Strasbourg, France
• Contact: Isabelle TALON, MD
• Phone: 33 3 88 12 72 96
• Email: Isabelle.TALON[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Pneumothorax is characterized by an abnormal presence of air in the pleural cavity, that is to say between the two layers of the pleura, the membrane that surrounds the lungs and lines the rib cage. "The patient is usually seized with sudden chest pain and difficulty in breathing.

In this retrospective research, the investigators wish to carry out an inventory of the management of spontaneous pneumothorax in adolescents within the University Hospitals of Strasbourg

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 134
• Est. completion date: December 2023
• Est. primary completion date: December 2023
• Gender: All
• Age group: 14 Years to 20 Years

Eligibility

Inclusion criteria:

• Adult patient (18-20 years old)

• Minor patient aged 14-17 years old

• Any gender

• Spontaneous pneumothorax without apparent cause, between 14 and 20 years old

• Patient operated on at the HUS between 2010 and 2021

• Patient not objecting to the reuse of their data for scientific research purposes.

• Holders of parental authority who do not object to the reuse of their child's data for scientific research purposes.

Exclusion criteria:

• Patient who has expressed his opposition to the reuse of his data for scientific research purposes.

• Holders of parental authority who have expressed their opposition to the reuse of their child's data for scientific research purposes.

• Secondary origin of the pathology: Cystic fibrosis, postoperative pneumothorax, post-traumatic,

• Subject having been treated initially in another structure without further information.

Related Conditions & MeSH terms

• Pneumothorax
• Pneumothorax, Spontaneous

Locations

Country	Name	City	State
France	Service de Chirurgie pédiatrique - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Retrospective description of the management of spontaneous pneumothorax in adolescents in the Strasbourg University Hospital	This study is retrospective, the analysis focuses on the medical records of patients treated at the Strasbourg University Hospital between between January 1, 2010 and December 31, 2021.	Files analysed retrospectively from January 1, 2010 and December 31, 2021 will be examined